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Background: We present a compendium of N-ethyl-N-nitrosourea (ENU)-induced mouse mutations, identified in
our laboratory over a period of 10 years either on the basis of phenotype or whole genome and/or whole exome
sequencing, and archived in the Mutagenetix database. Our purpose is threefold: 1) to formally describe many point
mutations, including those that were not previously disclosed in peer-reviewed publications; 2) to assess the
characteristics of these mutations; and 3) to estimate the likelihood that a missense mutation induced by ENU will
create a detectable phenotype.
Findings: In the context of an ENU mutagenesis program for C57BL/6J mice, a total of 185 phenotypes were
tracked to mutations in 129 genes. In addition, 402 incidental mutations were identified and predicted to affect
390 genes. As previously reported, ENU shows strand asymmetry in its induction of mutations, particularly favoring T
to A rather than A to T in the sense strand of coding regions and splice junctions. Some amino acid
substitutions are far more likely to be damaging than others, and some are far more likely to be observed. Indeed,
from among a total of 494 non-synonymous coding mutations, ENU was observed to create only 114 of the
182 possible amino acid substitutions that single base changes can achieve. Based on differences in overt null allele
frequencies observed in phenotypic vs. non-phenotypic mutation sets, we infer that ENU-induced missense
mutations create detectable phenotype only about 1 in 4.7 times. While the remaining mutations may not be
functionally neutral, they are, on average, beneath the limits of detection of the phenotypic assays we applied.
Conclusions: Collectively, these mutations add to our understanding of the chemical specificity of ENU, the types
of amino acid substitutions it creates, and its efficiency in causing phenovariance. Our data support the validity of
computational algorithms for the prediction of damage caused by amino acid substitutions, and may lead to
refined predictions as to whether specific amino acid changes are responsible for observed phenotypes. These data
form the basis for closer in silico estimations of the number of genes mutated to a state of phenovariance by ENU
within a population of G3 mice.
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Background
N-ethyl-N-nitrosourea (ENU) is a germline mutagen that
transfers its ethyl group to a nucleophilic nitrogen or
oxygen in nucleic acids [1-5]. These transferred ethyl
groups form DNA adducts that cause mispairing and
base-pair substitutions [4], which are transmitted from
spermatogonial stem cells to spermatids and finally
sperm [5].
Most of the mutations caused by ENU are single base-
pair substitutions (e.g. A/T to T/A transversions (44%)
or A/T to G/C transitions (38%)) [2,4,5]. When they fall
within coding regions, these mutations cause missense
(64%), splicing (26%), nonsense (10%), or make-sense
(i.e. a stop codon is converted back to an amino-acid-
coding codon) (~1%) mutations [4-6]. ENU can also dis-
rupt normal splicing, usually by changing nucleotides
that fall within introns, and occasionally by changing
nucleotides within coding region as well; i.e., by creating
novel splice sites.
Analysis of ENU-induced mutations revealed that ENU
action was more biased towards genes with higher G + C
content, while mutated nucleotides were more frequently
flanked by G or C [7]. As a result of this bias, it is prob-
able that amino acid changes specified by A/T to T/A or
A/T to G/C mutations would be affected more readily
than those that require G/C to C/G or G/C to T/A
changes [5]. ENU-induced mutations have been pre-
dicted to occur at a frequency of one mutation per every
1 to 2.7 Mbp of genomic DNA, depending upon strain
and dosage [5,8-10]. Still higher estimates of mutation
rate have recently been made, based on whole exome se-
quencing carried out using the DNA of G1 mice [11].
Considering the size of the mouse haploid genome and
accepting a rate of 1 mutation per Mbp of DNA, it is
estimated that each ENU-treated male (G0) gamete
would carry ~3000 mutations. It is further estimated that
~30 of these mutations would result in coding changes
in G1 animals [5,12]. And the preponderance of pheno-
type caused by ENU results from coding change, despite
rare examples to the contrary [13,14].
Here, we summarize mutations created using ENU
mutagenesis in our own laboratory and publicly
described during the past 10 years. Using both positional
cloning and massively parallel short read sequencing, we
have acquired a collection of mutations that clearly cause
phenotype, and also a collection of mutations that may
do so, but are not known to. These data permit infer-
ences concerning the frequency at which ENU-induced
missense errors will disrupt protein structure so as to
cause a detectable phenotype. We confirm that A→T
transversions and A→G transitions are the most com-
mon substitutions induced by ENU. In addition, we con-
firm that ENU shows marked asymmetry in its effects onsense vs. antisense strands. Of particular note, we esti-
mate the likelihood that an ENU-induced missense mu-
tation will, in the general case, cause damage of a degree
sufficient to elicit detectable phenovariance.
ENU mutagenesis program and phenotypic screens
Between 2001 and 2011, an ENU mutagenesis program
was operated by the Beutler laboratory at The Scripps
Research Institute in La Jolla, CA. A total of 38248 G1
and 113816 G3 mutant mice were generated and weaned
during those years, the latter resulting partly from a
backcross breeding strategy and partly from an intercross
breeding strategy (Figure 1). Phenotypic screening was
applied mostly to G3 mice, although G1 mice were occa-
sionally screened as well (see Methods). Dominant and
semidominant phenotypes were detected in both G1
mice (which harbor heterozygous mutations) and G3
mice (which harbor heterozygous and homozygous
mutations); some dominant and semidominant muta-
tions were detected in the homozygous state. Screens
included casual inspection for dysmorphologies affecting
limbs, tail, eyes, teeth, or other aspects of body form;
coat color and/or coat quality anomalies, abnormal body
size (runting or obesity), and neurobehavioral anomalies.
In addition, most G3 mice were subjected to one or
more immunological screens, which tested the integrity
of Toll-like receptor (TLR) signaling and inflammasome
signaling in thioglycolate-elicited macrophages; compe-
tence to resist infection by mouse cytomegalovirus
(MCMV), Rift Valley Fever Virus (RVFV), and influenza
virus in vivo; ability of macrophages to resist infection by
adenovirus and/or MCMV ex vivo; ability to mount a
humoral response to antigenic challenges; ability to resist
colitis induced by low doses of dextran sodium sulfate
(DSS); and ability to mount CD8 T cell and/or NK cell
dependent responses; and monitored blood cells for
anomalies of hematopoiesis and/or immune cell
development.
The Mutagenetix database
Mutagenetix is an online database of the ENU-induced
mouse mutations generated in the Beutler laboratory
(Center for the Genetics of Host Defense, UT Southwes-
tern Medical Center). Also described on Mutagenetix are
ENU-induced mutations generated in the Goodnow la-
boratory (The John Curtin School of Medical Research,
Australian National University); these are excluded from
analysis and discussion in this paper. For each pheno-
typic mutation, the position and phenotypic effect of the
mutation is given. In addition, detailed information
about the mutated gene, the localization, structure and
function of the encoded protein, and the putative mech-
anism of the mutation is provided, along with links to
the applicable literature resources; this information
Figure 1 Inbreeding strategies for generating G3 mice carrying homozygous ENU-induced mutations. (Left) The G0 male is mutagenized;
the G0’ female is a wild type C57BL/6J animal. G1 males are mated to wild type C57BL/6J females, and the resulting G2 daughters are
backcrossed to their G1 father to yield G3 mice. (Right) The G0 male is mutagenized; the G0 female (the daughter of another mutagenized male
and a wild type C57BL/6J female) also carries ENU-induced mutations. G1 siblings are intercrossed to obtain G2 mice. G3 mice are obtained from
intercrosses of G2 siblings.
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bases. A list of ENU-induced incidental mutations is also
available. The phenotypic and incidental mutations can
be sorted by gene name, chromosome, mode of inherit-
ance (or zygosity in the case of incidental mutations),
type of mutation, and the predicted effect of the muta-
tion as determined by PolyPhen-2 [15]. Mutagenetix also
provides up-to-date statistics of the mutation types,
ENU-induced DNA changes, and amino acid changes
found in the database.
Mutagenetix is intended for the sharing of discoveries
and of mutant stocks with the scientific community. It
provides information and links for obtaining most mu-
tant stocks, which are deposited and made available from
public repositories. It may also be useful as a template
for other databases of ENU-induced mutations. Muta-
genetix is open access and available at: http://mutagen-
etix.utsouthwestern.edu [16]. The Beutler laboratory also
uses LabArchives for storage of data. An archived ver-
sion of the database as of this writing is available at
http://dx.doi.org/10.6070/H4VD6WC9 in a LabArchives
Notebook [17].
To date, 190 phenovariants, detected among G1 and/or
G3 mice as a result of observation and the above-
mentioned phenotypic screens, have been publicly described
on Mutagenetix. Each instance of phenovariance was caused
by a single distinct mutation. 185 instances of phenovar-
iance were ascribed to specific mutations. These mutations
affected 129 genes. Multiple alleles were observed in the
case of 43 genes, as summarized in Table 1. All of the
phenotypes and their accompanying mutations are described
in detail at http://mutagenetix.utsouthwestern.edu [16], and
in the LabArchives notebook (http://dx.doi.org/10.6070/
H4VD6WC9) [17].Phenotypic vs. incidental mutations
The mutational cause of some phenotypes was deter-
mined through a candidate approach, based on similar
effects caused by other mutations in known genes. In
other cases, mapping was performed using either C3H/
HeN or C57BL/10J strains as mapping partners. Candi-
date genes within critical regions were examined by
DNA sequencing to identify the causative mutation. This
process originally depended upon computer-assisted pri-
mer design carried out one exon at a time using the pro-
gram Generunner (http://www.generunner.net/) (2001
through 2004). Later (2005 through 2008), a semi-
automated process involving the program Prime and a
Biomek FX robot was implemented for primer design
[12]. Still later (2008 through 2011), whole genome se-
quencing was performed using the ABI/LifeTechnologies
SOLiD system to detect mutations in the critical region
and elsewhere in the genome [18]. These mutations were
validated by capillary sequencing.
In this paper, the term “phenotypic mutations” refers
to those mutations known to cause phenotype, as deter-
mined by stringent methods including: identification of a
mutation within a gene for which other alleles are known
to cause an identical phenotype; positional restriction of
the phenotype to a critical region; genetic complementa-
tion analysis; phenotypic rescue by BAC transgenesis;
and/or gene knockout. The term “incidental mutations”
refers to those mutations that are not known to cause
phenotype, but were found in the course of whole gen-
ome sequencing, often performed in search of the cause
of a phenotype. Incidental mutations may indeed cause
phenotype, but were in no case responsible for the
phenotype of immediate interest that led to the perform-
ance of whole genome sequencing. Mutations within
Table 1 Genes with multiple ENU-induced alleles
Type of mutation Gene symbol Chromosome ENU-induced
alleles
Phenotypic Mutations Tlr9 9 8
Slc45a2 15 7
Adamts20 15 4
Lepr 4 4
Lyst 13 4
Myo5a 9 4
Nlrp3 11 4
Oca2 7 4
Tlr6 5 4
Atp7a X 3
Krt33a 11 3
Myd88 9 3
Tmprss6 15 3
Tyr 7 3
Agtpbp1 13 2
Atp11c X 2
Dock2 11 2
Edaradd 13 2
Hps5 7 2
Hr 14 2
Kcnj8 6 2
Kit 5 2
Krt25 11 2
Muc2 7 2
Ptpn6 6 2
Rag1 2 2
Rorb 19 2
Stat1 1 2
Tlr4 4 2
Tlr7 X 2
Zap70 1 2
Incidental Mutations A430110N23Rik 7 2
Chd2 7 2
Dido1 2 2
Fat1 8 2
Ftsj3 11 2
Gm8251 1 2
Gpr98 13 2
Nckap5 1 2
Nf1 11 2
Pde6b 5 2
Samd4 14 2
Ttll5 12 2
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of each intron were counted as incidental mutations;
deeper intronic mutations or intergenic mutations were
not counted in the analysis.
We also use the term “overt null alleles” to describe
frameshift, nonsense, and critical splicing mutations as
these have a high likelihood of affecting protein function.
We note that only nonsense and critical splicing alleles
are readily detectable by whole genome or whole exome
sequencing.
Types of alleles observed among phenotypic mutations
43 of the 185 phenotypes were autosomal dominant or
semidominant, 2 were X-linked dominant, 124 were
autosomal recessive, 8 were X-linked recessive, and 8
were not fully characterized with regard to inheritance
pattern (Table 2).
All phenotypes ascribed to mutations to date resulted
from nucleotide changes that alter coding sense. Among
the 185 phenotypic mutations just mentioned, 3 were
large deletions and 1 was a dinucleotide substitution.
Among the 181 remaining mutations (presumed to have
been caused by ENU and affecting single bases), 35 were
nonsense alleles, 3 were frameshift alleles (1 single base
deletion and 2 single base insertions), 21 were critical
splice junction defects altering either of the two nucleo-
tides at the proximal or distal ends of introns (17 affect-
ing donor sites and 4 affecting acceptor sites), and 11
were non-critical splice junction defects with documen-
ted effects on splicing (1 splice donor site created; 4
splice donor sites destroyed; 6 splice acceptor sites
destroyed). The distances of the non-critical splice site
mutations from the exon boundaries are shown in
Table 3. 111 of the phenotypic mutations were single-
base substitutions causing missense errors (Table 4).
In all, 59 ENU-induced phenotypes were caused by
readily detectable overt null alleles, as against 122 ENU-
induced phenotypes that were caused by other types of
allele (a ratio of 1 to 2.07, or 32.57% of all phenotypic
mutations). In our study as in others [4,7,19-21], the
most common cause of phenotypic change induced by
ENU is missense mutation.
Types of alleles observed among incidental mutations
A total of 402 incidental mutations affecting 390 genes
were observed and validated by capillary sequencing.
These mutations were derived from whole genome se-
quencing of 37 strains at G3 level or in subsequent gen-
erations, and one strain at the G1 level (in which 11
mutations were validated).
A total of 19 nonsense alleles, 1 critical splice acceptor
allele, and 8 critical splice donor alleles were detected for
a total of 28 overt null alleles. 330 missense alleles, 22
non-critical splice donor alleles, and 22 non-critical
Table 2 Mutation types generated by ENU
Phenotypic Incidental
Autosomal
recessive
X-linked
recessive
Autosomal
dominant (or
semidominant)
X-linked
dominant
Unknown Total % of
total
Homozygotes Heterozygotes Total % of
total
Missense 63 6 35 1 6 111 62.1 130 200 330 82.0
Noncritical
splice donor
site
4 0 0 0 1 5 2.8 9 13 22 5.5
Noncritical
splice
acceptor site
5 0 1 0 0 6 3.4 13 9 22 5.5
Nonsense† 27 1 5 1 1 35 19.8 7 12 19 4.7
Critical splice
donor site†
17 0 0 0 0 17 26.6 4 4 8 2.0
Critical splice
acceptor site†
3 0 1 0 0 4 2.2 0 1 1 0.3
Total 119* 7 42** 1 8 178 163 239 402
†Mutations considered to be overt nulls.
*Large deletions (3 alleles), small insertions (2 alleles), and a dinucleotide substitution (1 allele) were not included in the total.
**A small deletion (1 allele) was not included in the total.
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mutations, 163 were detected in the homozygous or
hemizygous state, whereas 239 were detected in the het-
erozygous state (Table 2).
The ratio of overt null alleles to other alleles is smaller
among incidental mutations than among phenotypic
mutations: 1 to 13.4, or 6.94% of the mutation total.
However, the frequency of specific individual base substi-
tutions (sense strand) did not differ significantly on com-
parison of phenotypic vs. incidental mutations.
A global estimate of how commonly ENU-induced
missense mutations cause phenovariance
By definition, 100% of the missense alleles in the pheno-
typic set are detectable by phenotypic screening. The re-
quirement that they cause phenotype enriches overt null
alleles among phenotypic mutations compared to inci-
dental mutations, and would similarly be expected to en-
rich deleterious missense alleles. Moreover, the degree of
enrichment of deleterious missense alleles, whether
overtly null, covertly null, or functionally hypomorphic
to the extent that they cause phenotype, should be
equivalent to that of overt null alleles. As described
above, overt null alleles accounted for 32.57% of all
ENU-induced phenotypic mutations, whereas they com-
prised only 6.94% of ENU-induced incidental mutations,
an enrichment of 4.70-fold in the phenotypic class rela-
tive to the incidental class. We infer that deleterious (i.e.
phenotypically detectable) missense alleles should also be
4.70 times more common among phenotypic mutations as
they are among incidental mutations. To a first approxi-
mation, we therefore infer that 21.3% of the missense
alleles induced by ENU and observed among incidental
mutations would be phenotypically detectable if a suitableassay for phenotype, equivalent in sensitivity to the visual
inspection and immunological assays we used, were
applied.The most and least deleterious types of ENU-induced
amino acid substitutions
Based on inspection of the codon table, a total of 182
types of coding changes can result from single nucleotide
substitutions, inclusive of the elimination of start codons
and stop codons. Not all of these changes can necessarily
be achieved by ENU mutagenesis. We compiled a list of
all non-splicing errors from both phenotypic and inci-
dental mutation lists. Among phenotypic mutations, 145
coding changes of 61 types were recorded. Among inci-
dental mutations, 349 coding changes of 103 types were
recorded. Both groups together accounted for 494 coding
changes of 114 types.
Certain amino acid changes were observed more fre-
quently within the phenotypic mutation set than within
the incidental mutation set. We take this to imply that
certain amino acid substitutions are more likely to be
deleterious. These changes include S→P, L→P, I→N,
C→R, and Y→D. Also overrepresented among the
phenotypic mutations as compared with incidental muta-
tions were all of the observed nonsense substitutions
Y→*, R→*, K→*, and Q→*, which are expected to be
strongly deleterious in most instances. On the other
hand, certain substitutions appear comparatively benign,
as they were found more commonly among incidental
mutations than among phenotypic mutations: T→I,
T→A, V→A, Y→H, N→K, and E→G, and several
others. A graphical comparison of phenotypic and inci-
dental mutations is displayed in Figure 2.
Table 3 Distance of splice site mutations from exon
boundary
Type of
mutation
Distance
from exon
boundary
(bp)
Allele Gene
symbol
Nature of
mutation
Critical splice
donor site
1 aoba Col4a4 G→A
1 bat Frem1 T→C
1 bullet gray Ap3b1 G→T
1 mister clean Hr G→A
1 tortellini Tgm3 G→A
1 warmflash Flt3 G→A
1 zuckerkuss Slc45a2 G→T
2 drunk Agtpbp1 T→A
2 feeble Slc15a4 T→A
2 frazz Dock2 T→A
2 frog Epha4 T→C
2 iron-man Trfr2 T→C
2 seal Col1a1 T→A
2 souris Lyst T→A
2 styx Inpp5d T→A
2 toffee Hps5 T→C
2 wobbley Atcay T→A
Non-critical splice
donor site
3 salt and pepper Dtnbp1 A→T
5 nut Myo5a G→A
5 odd Lepr G→T
6 atchoum Eif2ak4 T→C
Critical splice
acceptor site
2 Joker Itgb2 A→T
2 mask Tmprss6 A→G
2 rio Agtpbp1 A→G
2 torpid Tirap A→T
Non-critical splice
acceptor site
5 Sluggish Map3k8 T→A
7 Minnie Muted T→A
8 splotch2 Adamts20 T→A
11 frizz Dock2 T→A
13 poison Stat1 T→A
17 koala Mlph A→G
Splice donor
site created
57 jinx Unc13d C→A
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and specificity
Computational algorithms such as Polymorphism Pheno-
type (PolyPhen-2), MUpro, and Sort Intolerant from
Tolerant (SIFT) can be used to assess the likelihood of
loss of function when a given substitution is introduced
into a protein. PolyPhen-2 surveys the nature of the
amino acid change, secondary structure, and conserva-
tion among species to estimate the likelihood of damage;
splice site mutations and premature stops are notevaluated. We used PolyPhen-2 to assess all phenotypic
and incidental missense mutations in our dataset.
Comparison of the PolyPhen-2 predictions for pheno-
typic versus incidental mutations demonstrated that
PolyPhen-2 is quite sensitive in detecting damage po-
tential. Of 110 missense mutations known to cause
phenotype, all but 22 (80.0%) had scores equal to or
exceeding 0.95 (the lower cutoff for declaring a muta-
tion “probably damaging”) (Figure 3, left). The mean
score was 0.890. For 3 mutations, no information was
returned by PolyPhen-2.
The scores assigned to 330 incidental missense muta-
tions contrasted strikingly with those of phenotypic
mutations in distribution. Nearly half of all incidental
mutation scores were beneath 0.5 (mean score 0.578),
and only 125 (37.9%) had scores equal to or exceeding
0.95 (Figure 3, right). For 13 mutations no information
was returned by PolyPhen-2.
The specificity of PolyPhen-2 is more difficult to as-
sess, since there is no assurance that incidental muta-
tions do not cause phenotype. However, we have
estimated that approximately 21.3% of ENU-induced
missense mutations are likely to cause phenotype, which
would predict that 67 of 317 incidental mutations with
assignable scores should be damaging. As the actual
number of incidental mutations with PolyPhen-2 scores
exceeding 0.95 was 125, we therefore estimate that
PolyPhen-2 is at most 54% specific in declaring muta-
tions sufficiently deleterious to cause phenotype.
Strand asymmetry of ENU-induced mutations in both
phenotypic and incidental mutations
As previously reported [2,4,5], the most common nucleo-
tide substitutions caused by ENU are A→T transversions
and A→G transitions. Interestingly, however, the corre-
sponding T→A transversions and T→C transitions are
far more common in the sense strand, indicating strand
asymmetry in mutagenesis. In order to judge the signifi-
cance of strand asymmetry, we counted all nucleotide
substitutions predicted to cause a change in coding
sense, taking as our target the longest coding transcript
of every protein-encoding gene listed in the NCBI data-
base. We additionally counted all nucleotide substitu-
tions within critical splice junctions, assuming that these
mutations, too, would cause a change in coding sense.
Our intention was to evaluate the relative opportunity
for each missense, nonsense, or critical splice junction
mutation to occur, within either the sense strand or the
antisense strand of the coding region. We then made
statistical comparisons between observed base changes
in each strand based on exact binomial probability
(Table 5).
The null hypothesis holds that both sense and anti-
sense T residues that yield a coding change when
Table 4 Single-base ENU-induced missense mutations
Allele Gene
symbol
Nature of
mutation
Amino acid
substitution
Allele Gene
symbol
Nature of
mutation
Amino acid
substitution
3d Unc93b1 A→G H412R Meager Tlr9 A→T N210Y
4-limb clasper Rorb T→C S87P Muskatenwein Muc2 T→A I2172N
achtung Edaradd A→T I105F Myd88rev1 Myd88 T→A F285I
achtung2 Edar C→A P349Q ND1 Nlrp3 T→G C987W
add Tomt G→T R48L ND5 Nlrp3 T→C W956R
allia Cd247 A→T D36V ND6 Nlrp3 A→G R586G
artemis Bicc1 C→T T86I ND7 Nlrp3 T→C C816R
Bemr3 Rho T→C C185R otiose Irak4 T→C I327T
bronze Pah T→C L242P pale rider Tyr T→A V427D
brown Atp7a T→C I483T PanR1 Tnf C→A P217T
cartoon Mmp14 T→C S466P panr2 Ikbkg T→C L153P
Casper Kit A→G D676G phoebus Aqp3 T→C V43A
charbon Oca2 A→G T382A pinkie Rxra T→A I273N
CpG1 Tlr9 T→C L499P Plush Krt25 T→A L86Q
CpG11 Tlr9 T→C S358P pococurante Myd88 T→A I179N
CpG2 Tlr9 A→T Q985L Polished Krt33a T→G Y232D
CpG3 Tlr9 T→A V214E Polished2 Krt33a T→A C100R
CpG5 Tlr9 T→C L393P Possum Scn10a A→G T790A
CpG6 Tlr9 G→A G1028R Pretty2 Kit A→T I787F
CpG7 Tlr9 G→T R613L prune Hr T→G Y1082D
crab Cd79a T→A C50S queen Plcg2 T→A I346R
crusty Foxp3 T→A I350N quicksilver Oca2 G→A E453K
csp Ltbp3 T→C C452R Rough-fur Krt10 A→T E172V
Dalmatian Sox10 T→G N131K rsq1 Tlr7 C→T T68I
deer Mc1r A→G Y150C rsq2 Tlr7 A→T N182Y
domino Stat1 T→A V319E scanT Zbtb1 T→C C74R
eel Npr3 A→T I384F Schlendrian Muc2 G→T C561F
elektra Slfn2 T→A I135N siamese Tyr A→G H420R
Endeka Irf1 A→G D47G sinecure Rhbdf2 A->T I387F
F4/80 Emr1 A→G Y579C silver decerebrate Myo5a G→T S693I
flake Scd1 C→A T227K Sinuous Krt25 T→C S88P
ghost Tyr A→G H363R snowflake Oca2 C→T P459L
gimpy Wnt7a T→A C339S sos Kcnj8 T→C I318T
goofy Alx4 A→G H272R Southbeach Mc4r T→C L300P
grasshopper Rorb T→C M1T spelling Atp11c T→A I355K
grey goose Slc45a2 T→C L180P sphinx Gimap5 G→T G38C
honey Irf4 A→T R96S Spikey Krt33a T→A I353N
iconoclast Lck T→C L300P spin Ptpn6 T→A Y208N
inept Irf7 A→G D110G spin2 Ptpn6 T→C L86P
insouciant Tlr6 T→C V327A stamper-coat Hps6 T→A W71R
iron10 Cp T→C L1033P sweater Slc45a2 A→C H233P
jitter Kcnn2 T→C L168P Tigrou-like Atp7a C→T A998V
june gloom Slc45a2 T→C S378P trebia Zap70 A→T Y492F
king Card11 T→A L525Q TremorD Scn8a G→T W935L
Arnold et al. BMC Research Notes 2012, 5:577 Page 7 of 14
http://www.biomedcentral.com/1756-0500/5/577
Table 4 Single-base ENU-induced missense mutations (Continued)
L1 Gja8 T→C S50P Unnatural Klrb1c A→G D100G
L10 Crygb A→T I4F Untied Prkcb T→C Y417H
L1N Cryaa T→G Y141D Velvet Egfr A→G D857G
L23 Crygd T→A V76D walla Cd40lg T→C S221P
lackadaisical Myd88 A→G Y116C wanna Zap70 A→G H58R
languid Tlr2 A→T N487I wavedX Adam17 T→A F343I
lps3 Tlr4 A→T D709V whitemouse Oca2 T→A W725R
Lps4 Tlr4 G→A G724D woodrat Mbtps1 A→G Y496C
m2sd3 Tlr6 T→C I441T woolly Sgk3 T→C C346R
macro-1 Ifnar1 A→C T341P yuki Slc45a2 T→G S92R
macro-2 Ifnar1 A→G M1V zeitgeist Med30 A→T I44F
madcow Cars2 T→A S305T zigzag Lfng T→C V204A
Figure 2 Frequency of amino acid changes among phenotypic and incidental mutation classes. The line represents an equal frequency
between phenotypic and incidental mutations. Boxed amino acid changes represent those that occurred significantly more frequently in the
phenotypic vs. incidental mutation set, or vice versa.
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http://www.biomedcentral.com/1756-0500/5/577mutated to an A are equally valid targets for mutagen-
esis. This hypothesis would predict that T→A mutation
in the sense strand should occur 82.817% as often as
T→A mutation in the antisense strand. However, with a
P value of 0.00397, the hypothesis is rejected for pheno-
typic mutations; with a P value of 0.000435 it is rejected
for incidental mutations; and with a P value of
0.00000725 it is rejected for both phenotypic and inci-
dental mutations. T→A substitution actually occurs 1.7
times more frequently in the sense strand as in the anti-
sense strand.
Interestingly T→C mutations show even stronger
strand asymmetry among phenotypic mutations, and are
over-represented to a highly significant degree in the
sense strand (P = 0.00071), but are not over-represented
among incidental mutations. This observation is consist-
ent with the interpretation that T→C mutations in the
sense strand tend to cause more destructive effects than
A→G mutations (which correspond to T→C mutations
in the antisense strand). T→C substitutions in the sense
strand disproportionately affect valine, leucine, cysteine,
serine, methionine, and all of the aromatic amino acids
as compared to A→G. A selective trend toward signifi-
cance among phenotypic mutations is also observed for
A→C/T→G (sense/antisense) among phenotypic muta-
tions, and for G→A/C→T (sense/antisense) among both
phenotypic and incidental mutations (Table 5).
These findings are consistent with the earlier observa-
tions of Takahasi et al., who posited that transcription-
coupled repair mechanisms might account for strand
asymmetry [21]. However, it is possible that selection
bias based on the nature of coding change may also con-
tribute to the effect measured in phenotypic mutations.
Discussion
We have compared two classes of ENU-induced muta-
tions: ‘phenotypic’ mutations (mutations identified as0.0
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Phenotypic Mutations
Figure 3 PolyPhen-2 scores of phenotypic and incidental mutations. Rcausative for particular phenotypes) and ‘incidental’
mutations (mutations that are not known to cause
phenotype). Phenotypic and incidental mutations differed
in several respects, permitting us to make several conclu-
sions regarding the creation of phenotype by ENU. First,
the frequency of different types of alleles (i.e. missense,
nonsense, splice donor site, etc.) observed among pheno-
typic mutations in both G1 and G3 mice differed signifi-
cantly from those of incidental mutations. In particular,
overt null alleles, considered to include frameshift, non-
sense, and critical splicing mutations, were far more fre-
quent (~4.7x increased) among phenotypic mutations
than incidental mutations. This enrichment for deleteri-
ous alleles reflects the process of selection that identifies
mutations of the phenotypic class. By considering that
the same selective process also enriches deleterious
alleles of other types, we calculated that globally, ENU-
induced missense mutations (the most common type of
ENU-induced mutation) may be expected to cause de-
tectable phenovariance at a frequency of approximately
21.3%.
The efficiency of ENU mutagenesis in the creation of
phenotype in mice is thus relatively low, albeit com-
pensated by the abundance of mutations that are trans-
mitted to each G1 mouse. It must be emphasized, of
course, that declaration of “phenotype” is entirely
dependent on assay sensitivity and precision. The data
we have presented are derived from a number of im-
munological assays and from relatively casual inspec-
tion of animals for visible or behavioral abnormalities.
In the case of TLR signaling screens, assay variance
(measurement of TNF secretion by peritoneal macro-
phages) typically encompasses a 10 fold range from
lowest to highest value. If, in an imaginary scenario,
the phenotype at issue were instead defined by meas-
urement of a particular enzymatic activity, and if the
relevant assay could be performed with precisionN = 317
Incidental Mutations
ed lines indicate means.
Table 5 Frequencies of ENU-induced DNA base changes in the sense strand
DNA base change p† Phenotypic mutations Incidental mutations Phenotypic + Incidental mutations
Mutation number P values* Mutation number P values* Total number P values*
A→T 0.5470 23 0.00397 39 0.000435 62 0.00000725
T→A 0.4530 39 64 103
A→G 0.5780 20 0.00071 70 0.9425 90 0.00322
T→C 0.4220 36 66 102
A→C 0.5308 2 0.06310 8 0.3982 10 0.09730
T→G 0.4692 7 9 16
G→T 0.5341 10 0.6600 14 0.3876 24 0.4289
C→A 0.4659 8 15 23
G→A 0.5563 9 0.1202 35 0.1401 44 0.0533
C→T 0.4437 13 37 50
G→C 0.5187 0 – 1 1.0 1 1.0
C→G 0.4813 0 0 0
Total 167** 358†† 527
†Relative probability of non-synonymous nucleotide change in the sense strand (see Methods).
*Likelihood of observed or greater departure from the expected ratio by exact binomial calculation.
**Not included were 11 non-critical splice junction mutations, 3 large deletions, 2 single base insertions, 1 single base deletion, and 1 dinucleotide transition.
††Not included were 44 non-critical splice junction mutations.
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mean, a greater fraction of missense mutations might
be scored as phenovariants.
In examining phenotypic versus incidental mutations,
we also observed that certain amino acid substitutions
were more likely to be found among either the pheno-
typic or the incidental class of mutations. For example,
S→P, L→P, I→N, C→R, Y→D, Y→*, Q→*, K→*, and
R→* were more common among phenotypic mutations
than incidental mutations, strongly suggesting that, irre-
spective of location within the polypeptide chain, these
specific substitutions are more likely to be damaging to
protein function than not. In many cases, these substitu-
tions are predicted to result in major changes to the bio-
chemical properties of the protein locally, such as polar
to nonpolar (S→P), nonpolar to basic (C→R), or nonpo-
lar to polar (I→N). Substitutions to proline (as in S→P
and L→P) also often conformationally constrain second-
ary structure due to the cyclic structure of proline. Con-
versely, the substitutions T→I, T→A, V→A, V→E,
N→K, and E→G occurred more frequently among
incidental mutations than phenotypic mutations. These
data suggest that in general, certain amino acid
substitutions are detrimental and others are innocuous. Be-
cause ENU tends to affect some nucleotides preferentially
and exhibits strand specificity, noted earlier by others
[2,4,5,21] and confirmed here by our own studies, its ten-
dency to generate changes that cause phenotype is best
accomplished empirically, as we have done here.
As an extension of the analysis of specific amino
acid substitutions, we also evaluated phenotypic and
incidental missense mutations using PolyPhen-2, whichcomputationally predicts the impact of sequence vari-
ation on protein function. PolyPhen-2 has been reported
to achieve accurate positive prediction rates of 92% and
73% using the HumDiv- and HumVar- trained program
versions, respectively [15]. In our analysis we used the
HumDiv-trained PolyPhen-2, as recommended for evalu-
ation of rare alleles at loci that may potentially be
involved in complex phenotypes. In agreement with
Adzhubei et al. we found that among phenotypic muta-
tions, all of which by definition are damaging, 80%
scored at 0.95 or higher and were thus correctly labeled
as “probably damaging.”
PolyPhen-2 was at best about 54% specific in labeling
incidental mutations as “probably damaging.” We note,
however, that the creation of a phenotype may often re-
quire more than causing damage, however slight, to pro-
tein function; hence, “causing phenovariance” may be
viewed as a more stringent criterion than “causing dam-
age.” For this reason, the apparent low specificity of
PolyPhen-2 is not unexpected.
Conclusion
We estimated that 21.3% of ENU-induced missense
mutations cause phenotypes detectable in typical screen-
ing assays. We also identified those ENU-induced amino
acid substitutions that are most likely—and those that
are least likely—to cause phenotypic change. Knowledge
of the types of mutations caused by ENU and their
relative likelihood of causing phenotype may be incorpo-
rated into estimates of genome saturation when a screen
has been performed on a specific population of G3
mice. Such an estimate is best made by simulating
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mouse has been defined and well annotated, the charac-
teristics of ENU-induced mutations have been relatively
well studied, and the frequency of ENU-induced muta-
tions has been estimated, simulations can closely ap-
proximate mutagenesis as it is actually performed. While
it is safe to assume that overt null alleles observed in
simulation would indeed be deleterious, it has been more
difficult to determine the likelihood that individual mis-
sense mutations will lead to perceptible phenotypic
change. Our data provide a reasonable basis for making
such inferences, and for estimating the fraction of genes
that have been mutated to a state of phenovariance.
Methods
Links to the full protocols can be found in Table 6.
Mice
Mice were housed and bred under specific pathogen free
conditions in polycarbonate cages with corn cob bedding
in The Scripps Research Institute vivarium. Mice were
housed at four adults per cage in self-watering cage racks
kept in 25°C rooms with a 12 h light/12 h dark light
cycle. Mice had unlimited access to rodent chow and
water. C57BL/6J and C57BL/10J mice were purchased
from The Jackson Laboratory. All studies were per-
formed in accordance with the guidelines established by
the Institutional Animal Care and Use Committee of
The Scripps Research Institute.
ENU Mutagenesis and genetic mapping of mutations
ENU was prepared fresh for each set of injections at 100
mg/ml, as previously described [20]. The precise concen-
tration of ENU was determined by absorbance at λ = 398
nm and calculated based on the formula 0.72 O.D. = 1
mg/ml of ENU. After ENU preparation, C57BL/6J male
mice were anesthetized with a xylazine/ketamineTable 6 Protocols and screens used to identify ENU-induced m
Protocol or screen
Mutagenizing male mice with ENU
Genetic Mapping: Whole Genome Mapping and Fine Mapping
Genetic Mapping by Bulk Segregation Analysis
Ex Vivo Macrophage Screen for Control of Viral Infection
In Vivo Rift Valley Fever Virus (RVFV) Susceptibility Screen
Toll-like Receptor (TLR) Signaling Screen
NALP3 Inflammasome Screen
MCMV Susceptibility and Resistance Screen
T-dependent Humoral Response Screen
T-independent B Cell Response Screen
DSS-induced Colitis Screen
In Vivo NK Cell and CD8+ T Cell Cytotoxicity Screeninjection (100 μl i.m.) and injected i.p. with 100 mg
ENU/kg of body weight once per week for three weeks.
After the last injection, the mice were housed one per
cage for 12 weeks to allow for recovery of fertility.
To map a mutation, the mutant stock (C57BL/6J back-
ground) was outcrossed to a second strain (C57BL/10J
or C3H/HeN) and then F1 hybrids were either inter-
crossed or backcrossed to the mutant stock (for recessive
mutations) or mated to the outcross strain (for dominant
mutations) [20]. Offspring of F1 mice were subsequently
analyzed phenotypically (see below for descriptions of
the phenotypic screens used) and a critical region was
established by genetic linkage mapping using approxi-
mately 120 polymorphic markers across the whole gen-
ome and additional markers close to the mutation as
necessary. Bulk segregation analysis (BSA) was used to
map some mutations, as described [22]. Incidental muta-
tion data were obtained by whole genome sequencing
using versions 2–4 of SOLiD technology (Life Technolo-
gies, Grand Island, NY).
Phenotypic screens
In total, approximately 100,000 G3 mice from 8,000 ped-
igrees were subjected to screening. Mice were allocated
to screens such that some mice were used in only one
screen, whereas others were tested serially in several
screens; non-invasive screening was performed preceding
invasive screening. Mice were subjected to two screens
at most, with a one week rest period between screens.
Statistical analysis of data from each screen was per-
formed as described in references cited on the relevant
mutation page in Mutagenetix or the LabArchives
Notebook.
MCMV susceptibility and resistance screen
MCMV (Smith strain) was propagated in BALB/c mice
and harvested from salivary glands. To screen forutations
On-line resource
http://dx.doi.org/10.6070/H4QN64NZ
http://dx.doi.org/10.6070/H4G44N67
http://dx.doi.org/10.6070/H4KW5CX7
http://dx.doi.org/10.6070/H4Z60KZS
http://dx.doi.org/10.6070/H4JW8BSV
http://dx.doi.org/10.6070/H4NP22CR
http://dx.doi.org/10.6070/H4BG2KWT
http://dx.doi.org/10.6070/H41Z429S
http://dx.doi.org/10.6070/H4X63JTD
http://dx.doi.org/10.6070/H4SF2T33
http://dx.doi.org/10.6070/H42Z13F5
http://dx.doi.org/10.6070/H4PN93HK
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approximately 22,600 female mice were inoculated intra-
peritoneally with either 1x105 pfu MCMV, an inoculum
normally harmless to C57BL/6J mice, or 1x106 pfu
MCMV, a dose that typically causes death of C57BL/6J
mice by five days post-infection. Mice were observed
for sickness or death for one week following infection.
Putative susceptible mutants were those that sickened
or died in response to infection with 1x105 pfu MCMV;
putative resistant mutants were those that survived after
infection with 1x106 pfu MCMV.
Toll-like receptor (TLR) signaling screen
Briefly, thioglycolate-elicited peritoneal exudate cells
were isolated from approximately 39,000 male and fe-
male G3 mice, plated at 5x104 cells/well in 96-well
plates, and stimulated with the following TLR ligands at
the indicated concentrations: lipopolysaccharide (LPS;
800 pg/ml), poly(I:C) (150 μg/mL), Pam3CSK4 (30 ng/
mL), resiquimod (30 ng/mL), CpG oligodeoxynucleotides
(15 μg/mL), peptidoglycan (1 μg/mL), MALP-2 (600 pg/
mL). Cells were stimulated for 4 h at 37°C/5% CO2 in a
humidified incubator. The concentration of tumor ne-
crosis factor (TNF)-α in the culture medium was deter-
mined by bioassay using L-929 cells, for which TNF is
cytotoxic.
NALP3 inflammasome screen
Peritoneal exudate cells isolated from approximately
7,500 male and female G3 mice and plated as described
above were stimulated with LPS (100 ng/mL) for 4 h, fol-
lowed by nigericin (10 μg/mL) for 1 h at 37°C/5% CO2
in a humidified incubator. The concentration of interleu-
kin (IL)-1β in the culture medium was determined by
ELISA.
In vivo RVFV susceptibility screen
The mutagen-attenuated recombinant strain arMP-12
[24] was used for the screen and propagated in
VeroE6 cells. Approximately 900 female G3 mice
were injected intraperitoneally with 1x105 pfu of
RVFV, which initiates an infection controlled by
C57BL/6J mice with no signs of illness. The mice
were observed daily for signs of illness; symptomatic
mice were sacrificed and blood, liver, spleen, and
brain collected. Viral titers were measured in the
infected tissues by standard plaque assay using
VeroE6 cells.
Ex vivo macrophage screen for control of viral infection
The screen was performed as described [25]. Briefly, 105
thioglycolate-elicited peritoneal exudate cells isolated
from approximately 7,000 male and female G3 mice
were infected for 24 h with MCMV-GFP [26] at MOI 1,or for 72 h with Ad5-F16-GFP [27] at 104 particles per
cell. Cells were incubated at 37°C with 5% CO2 in a hu-
midified incubator. The number of infected cells was
determined by counting the number of GFP+ cells by
flow cytometry. MCMV-GFP was a gift from Dr. Chris
Benedict (La Jolla Institute of Allergy and Immunology,
La Jolla, CA) and was propagated as described [28].
Ad5-F16-GFP was a gift from Dr. Glen Nemerow (The
Scripps Research Institute, La Jolla, CA) and was propa-
gated as described [27,29].
T-dependent and T-independent humoral response screen
Briefly, approximately 7,000 male G3 mice were immu-
nized with 2 x 106 IU of a recombinant, non-replicating
Semliki Forest Virus vector (rSFV) encoding βGal by i.p.
injection. After ten days, mice were also immunized with
50 μg of 4-hydroxy-3-nitrophenylacetyl-AminoEthylCar-
boxyMethyl-Ficoll (NP-Ficoll). Fourteen days after the
initial immunization, blood was collected from the retro-
orbital sinus and specific antibodies were measured. To
detect βGal-specific IgG or NP-specific IgM, 96-well
round bottom plates were coated with 2 μg/mL βGal in
phosphate buffered saline or 5 μg/mL NP23-BSA for
ELISA. Putative mutants exhibited deficient antibody
responses.
DSS-induced colitis screen
To identify G3 mice susceptible to dextran sulfate so-
dium (DSS)-induced colitis, approximately 6,000 male
and female G3 mice were exposed for one week to 1%
(w/v) DSS in the drinking water, a concentration harm-
less to C57BL/6J animals. Mice were weighed daily and
those displaying loss of at least 8% of their original
weight by day 6 of treatment were considered putative
mutants.
In vivo NK cell and CD8+ T cell cytotoxicity screen
Briefly, approximately 4,000 male and female G3 mice
and control Tap1−/− mice were immunized i.p. with 107
mouse splenocytes expressing membrane-associated ov-
albumin driven by an actin promoter (act-mOVA) [30].
Eight days after immunization, 1.33x105 carboxyfluores-
cein succinimidyl ester (CFSE)-labeled splenocytes from
syngeneic C57BL/6J mice loaded with the OVA-derived
SIINFEKL peptide were injected into the tail vein of
immunized mice as cytolytic T lymphocyte (CTL) target
cells. Also injected were 1.33x105 CSFE-labeled spleno-
cytes from Tap1−/− mice as NK cell target cells, and
1.33x105 CSFE-labeled C57BL/6J splenocytes as control
cells. Each target cell population was labeled with a differ-
ent intensity of CSFE. Two days after injection of CSFE-
labeled cells, 200 μl of blood from the orbital sinus of each
mouse was extracted and the CSFE-labeled target cells
were counted by flow cytometry. The percentage of NK
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gets killed = [1-(target cells/control cells)/(ratio of target
cells:control cells in Tap1−/− mouse)] x 100. G3 mice that
failed to kill NK or CTL target cells were considered as pu-
tative mutants.Statistical analysis
The statistical significance of differences in the frequency
of particular nucleotide changes induced in the sense
versus antisense strands was calculated as the exact bino-
mial probability, where k was the number of observed
mutations and p was the probability of a particular non-
synonymous coding change or critical splice junction
change in the sense strand versus the antisense strand.
As an example, to calculate p for A→G substitutions,
the number of A→G sense strand substitutions predicted
to cause nonsynonymous coding change or critical splice
junction change was divided by the sum of A→G and
T→C sense strand substitutions predicted to cause non-
synonymous coding change or critical splice junction
change, given that a T→C change in the sense strand
corresponds to an A→G change in the antisense strand.
The number of each of the 12 possible nucleotide substi-
tutions predicted to cause nonsynonymous coding
change or critical splice junction change in the sense
strand is shown in Table 7.Availability of supporting data
The data set supporting the results of this article is avail-
able in the Mutagenetix database, http://mutagenetix.
utsouthwestern.edu, and in an archived version of the
database in a LabArchives Notebook, http://dx.doi.org/
10.6070/H4VD6WC9.Table 7 Nucleotide changes that alter coding sense
Mutation Coding sequence* Critical Splice Junctions* Total*
A→C 7557737 147033 7704770
A→G 6938327 147033 7085360
A→T 7856324 147033 8003357
C→A 6939729 93629 7033358
C→G 7387012 93629 7480641
C→T 5071174 93629 5164803
G→A 6231339 243302 6474641
G→C 7818308 243302 8061610
G→T 7818308 243302 8061610
T→A 6415261 212884 6628145
T→C 4959605 212884 5172489
T→G 6597408 212884 6810292
Total 35258130 696852 35954982
* Values are for the sense strand.Competing interests
The authors declare that they have no competing interests.
Author contributions
CAN, MJB, MB, ALB, KB, BC, KC, XD, CE, PG, KH, HH, ZJ, PK, DP, SR, OMS, LS,
KT, WT, SW, and NX performed phenotypic screening and genetic mapping.
XL performed mouse husbandry, cryopreservation, and transgenesis. SL and
YX analyzed mutation statistics. EMYM, ARM, and NGS wrote the Mutagenetix
records pages describing mutations. YX analyzed DNA sequence and
mapping data. BB conceived of the study and its design. EMYM, ARM, and BB
compiled data, analyzed data, and wrote the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
This work was supported by National Institutes of Health grants AI070167-
06A1, AI100627-01, and GM067759-10, and the Bill and Melinda Gates
Foundation.
Author details
1Department of Genetics, The Scripps Research Institute, La Jolla, CA 92037,
USA. 2Center for Genetics of Host Defense, UT Southwestern Medical Center,
5323 Harry Hines Boulevard, 8505, Suite NB9-202D, Dallas, TX 75390, USA.
Received: 9 July 2012 Accepted: 3 September 2012
Published: 24 October 2012
References
1. Cook MC, Vinuesa CG, Goodnow CC: ENU-mutagenesis: insight into
immune function and pathology. Curr Opin Immunol 2006, 18(5):627–633.
2. Cordes SP: N-ethyl-N-nitrosourea mutagenesis: boarding the mouse
mutant express. Microbiol Mol Biol Rev 2005, 69(3):426–439.
3. Gondo Y, Fukumura R, Murata T, Makino S: Next-generation gene targeting
in the mouse for functional genomics. BMB Rep 2009,
42(6):315–323.
4. Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A: Mouse ENU
mutagenesis. Hum Mol Genet 1999, 8(10):1955–1963.
5. Nguyen N, Judd LM, Kalantzis A, Whittle B, Giraud AS, van Driel IR: Random
mutagenesis of the mouse genome: a strategy for discovering gene
function and the molecular basis of disease. Am J Physiol Gastrointest
Liver Physiol 2011, 300(1):G1–G11.
6. Noveroske JK, Weber JS, Justice MJ: The mutagenic action of N-ethyl-N-
nitrosourea in the mouse. Mamm Genome 2000, 11(7):478–483.
7. Barbaric I, Wells S, Russ A, Dear TN: Spectrum of ENU-induced mutations in
phenotype-driven and gene-driven screens in the mouse. Environ Mol
Mutagen 2007, 48(2):124–142.
8. Quwailid MM, Hugill A, Dear N, Vizor L, Wells S, Horner E, Fuller S, Weedon J,
McMath H, Woodman P, Edwards D, Campbell D, Rodger S, Carey J, Roberts
A, Glenister P, Lalanne Z, Parkinson N, Coghill EL, McKeone R, Cox S, Willan J,
Greenfield A, Keays D, Brady S, Spurr N, Gray I, Hunter J, Brown SD, Cox RD:
A gene-driven ENU-based approach to generating an allelic series in any
gene. Mamm Genome 2004, 15(8):585–591.
9. Papathanasiou P, Goodnow CC: Connecting mammalian genome with
phenome by ENU mouse mutagenesis: gene combinations specifying
the immune system. Annu Rev Genet 2005, 39:241–262.
10. Nolan PM, Hugill A, Cox RD: ENU mutagenesis in the mouse: application
to human genetic disease. Brief Funct Genomic Proteomic 2002,
1(3):278–289.
11. Andrews TD, Whittle B, Field MA, Balakishnan B, Zhang Y, Shao Y, Cho V, Kirk
M, Singh M, Xia Y, Hager J, Winslade S, Sjollema G, Beutler B, Enders A,
Goodnow CC: Massively parallel sequencing of the mouse exome to
accurately identify rare, induced mutations: an immediate source for
thousands of new mouse models. Open Biol 2012, 2:120061.
12. Beutler B, Du X, Xia Y: Precis on forward genetics in mice. Nat Immunol
2007, 8(7):659–664.
13. Masuya H, Sezutsu H, Sakuraba Y, Sagai T, Hosoya M, Kaneda H, Miura I,
Kobayashi K, Sumiyama K, Shimizu A, Nagano J, Yokoyama H, Kaneko S,
Sakurai N, Okagaki Y, Noda T, Wakana S, Gondo Y, Shiroishi T: A series of
ENU-induced single-base substitutions in a long-range cis-element
altering Sonic hedgehog expression in the developing mouse limb bud.
Genomics 2007, 89(2):207–214.
Arnold et al. BMC Research Notes 2012, 5:577 Page 14 of 14
http://www.biomedcentral.com/1756-0500/5/57714. Lewis MA, Quint E, Glazier AM, Fuchs H, De Angelis MH, Langford C, van
Dongen S, Abreu-Goodger C, Piipari M, Redshaw N, Dalmay T, Moreno-
Pelayo MA, Enright AJ, Steel KP: An ENU-induced mutation of miR-96
associated with progressive hearing loss in mice. Nat Genet 2009,
41(5):614–618.
15. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P,
Kondrashov AS, Sunyaev SR: A method and server for predicting
damaging missense mutations. Nat Methods 2010, 7(4):248–249.
16. Mutagenetix database. http://mutagenetix.utsouthwestern.edu.
17. Beutler B, colleagues: Archived mutation data. LabArchives; 2012.
http://dx.doi.org/10.6070/H4VD6WC9.
18. Arnold CN, Xia Y, Lin P, Ross C, Schwander M, Smart NG, Muller U, Beutler B:
Rapid identification of a disease allele in mouse through whole genome
sequencing and bulk segregation analysis. Genetics 2011, 187(3):633–641.
19. Nolan PM, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray IC, Vizor L,
Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu
X, McCormack S, Pickford K, Selley R, Wells C, Tymowska-Lalanne Z, Roby P,
Glenister P, Thornton C, Thaung C, Stevenson JA, Arkell R, Mburu P, Hardisty
R, Kiernan A, Erven A, Steel KP, Voegeling S, Guenet JL, Nickols C, Sadri R,
Nasse M, Isaacs A, Davies K, Browne M, Fisher EM, Martin J, Rastan S, Brown
SD, Hunter J: A systematic, genome-wide, phenotype-driven mutagenesis
programme for gene function studies in the mouse. Nat Genet 2000,
25(4):440–443.
20. Georgel P, Du X, Hoebe K, Beutler B: ENU mutagenesis in mice. Methods
Mol Biol 2008, 415:1–16.
21. Takahasi KR, Sakuraba Y, Gondo Y: Mutational pattern and frequency of
induced nucleotide changes in mouse ENU mutagenesis. BMC Mol Biol
2007, 8:52.
22. Xia Y, Won S, Du X, Lin P, Ross C, La Vine D, Wiltshire S, Leiva G, Vidal SM,
Whittle B, Goodnow CC, Koziol J, Moresco EM, Beutler B: Bulk segregation
mapping of mutations in closely related strains of mice. Genetics 2010,
186(4):1139–1146.
23. Crozat K, Georgel P, Rutschmann S, Mann N, Du X, Hoebe K, Beutler B:
Analysis of the MCMV resistome by ENU mutagenesis. Mamm Genome
2006, 17(5):398–406.
24. Won S, Ikegami T, Peters CJ, Makino S: NSm and 78-kDa proteins of Rift
Valley fever virus are nonessential for viral replication in cell culture.
J Virol 2006, 80(16):8274–8278.
25. Won S, Eidenschenk C, Arnold CN, Siggs OM, Sun L, Brandl K, Mullen TM,
Nemerow GR, Moresco EM, Beutler B: Increased susceptibility to DNA virus
infection in mice with a GCN2 mutation. J Virol 2012, 86(3):1802–1808.
26. Mathys S, Schroeder T, Ellwart J, Koszinowski UH, Messerle M, Just U:
Dendritic cells under influence of mouse cytomegalovirus have a
physiologic dual role: to initiate and to restrict T cell activation. J Infect
Dis 2003, 187(6):988–999.
27. Hsu C, Boysen M, Gritton LD, Frosst PD, Nemerow GR, Von Seggern DJ: In
vitro dendritic cell infection by pseudotyped adenoviral vectors does not
correlate with their in vivo immunogenicity. Virology 2005, 332(1):1–7.
28. Loewendorf A, Kruger C, Borst EM, Wagner M, Just U, Messerle M:
Identification of a mouse cytomegalovirus gene selectively targeting
CD86 expression on antigen-presenting cells. J Virol 2004,
78(23):13062–13071.
29. Von Seggern DJ, Huang S, Fleck SK, Stevenson SC, Nemerow GR:
Adenovirus vector pseudotyping in fiber-expressing cell lines: improved
transduction of Epstein-Barr virus-transformed B cells. J Virol 2000,
74(1):354–362.
30. Ehst BD, Ingulli E, Jenkins MK: Development of a novel transgenic mouse
for the study of interactions between CD4 and CD8 T cells during graft
rejection. Am J Transplant 2003, 3(11):1355–1362.
doi:10.1186/1756-0500-5-577
Cite this article as: Arnold et al.: ENU-induced phenovariance in mice:
inferences from 587 mutations. BMC Research Notes 2012 5:577.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
